Literature DB >> 3497176

Antibody response to human immunodeficiency virus in homosexual men. Relation of antibody specificity, titer, and isotype to clinical status, severity of immunodeficiency, and disease progression.

J S McDougal, M S Kennedy, J K Nicholson, T J Spira, H W Jaffe, J E Kaplan, D B Fishbein, P O'Malley, C H Aloisio, C M Black.   

Abstract

The titers and isotypes of antibodies to specific proteins of the human immunodeficiency virus were determined by Western blot analysis of sera from 107 homosexual men. Antibody titers were generally lower in sera from patients with the acquired immunodeficiency syndrome (AIDS) and in sera from men whose condition subsequently progressed to AIDS than in sera from men who had not progressed to AIDS. We found no evidence of isotypic prominence or restriction of the antibody response. In multivariate analysis, lower levels of CD4 helper cells were most highly associated with progression to AIDS. Lower antibody titers to the envelope protein gp110, the core protein p24, and the reverse transcriptase enzyme p51/65 were also predictive of progression to AIDS independent of their association with CD4 cell levels. These data suggest that differences in antibody levels are not simply a consequence of severe immunodeficiency but may be markers for control of infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3497176      PMCID: PMC442240          DOI: 10.1172/JCI113075

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Place of IgM antibody testing in HIV serology.

Authors:  J V Parry; P P Mortimer
Journal:  Lancet       Date:  1986-10-25       Impact factor: 79.321

2.  Generalized lymphadenopathy in homosexual men.

Authors:  C E Metroka; S Cunningham-Rundles; M S Pollack; J A Sonnabend; J M Davis; B Gordon; R D Fernandez; J Mouradian
Journal:  Ann Intern Med       Date:  1983-11       Impact factor: 25.391

3.  Immunological studies of homosexual men with immunodeficiency and Kaposi's sarcoma.

Authors:  R W Schroff; M S Gottlieb; H E Prince; L L Chai; J L Fahey
Journal:  Clin Immunol Immunopathol       Date:  1983-06

Review 4.  The differentiation and function of human T lymphocytes.

Authors:  E L Reinherz; S F Schlossman
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

5.  Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes.

Authors:  D Klatzmann; F Barré-Sinoussi; M T Nugeyre; C Danquet; E Vilmer; C Griscelli; F Brun-Veziret; C Rouzioux; J C Gluckman; J C Chermann
Journal:  Science       Date:  1984-07-06       Impact factor: 47.728

6.  Longitudinal study of persistent generalised lymphadenopathy in homosexual men: relation to acquired immunodeficiency syndrome.

Authors:  U Mathur-Wagh; R W Enlow; I Spigland; R J Winchester; H S Sacks; E Rorat; S R Yancovitz; M J Klein; D C William; D Mildvan
Journal:  Lancet       Date:  1984-05-12       Impact factor: 79.321

7.  B-cell immunodeficiency in acquired immune deficiency syndrome.

Authors:  A J Ammann; G Schiffman; D Abrams; P Volberding; J Ziegler; M Conant
Journal:  JAMA       Date:  1984-03-16       Impact factor: 56.272

8.  Immunoregulatory subsets of the T helper and T suppressor cell populations in homosexual men with chronic unexplained lymphadenopathy.

Authors:  J K Nicholson; J S McDougal; T J Spira; G D Cross; B M Jones; E L Reinherz
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

9.  Acquired immune dysfunction in homosexual men: immunologic profiles.

Authors:  A J Ammann; D Abrams; M Conant; D Chudwin; M Cowan; P Volberding; B Lewis; C Casavant
Journal:  Clin Immunol Immunopathol       Date:  1983-06

10.  Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS.

Authors:  J Schüpbach; M Popovic; R V Gilden; M A Gonda; M G Sarngadharan; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  18 in total

1.  Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection.

Authors:  Nicole L Yates; Judith T Lucas; Tracy L Nolen; Nathan A Vandergrift; Kelly A Soderberg; Kelly E Seaton; Thomas N Denny; Barton F Haynes; Myron S Cohen; Georgia D Tomaras
Journal:  AIDS       Date:  2011-11-13       Impact factor: 4.177

2.  Mechanisms of human immunodeficiency virus Type 1 (HIV-1) neutralization: irreversible inactivation of infectivity by anti-HIV-1 antibody.

Authors:  J S McDougal; M S Kennedy; S L Orloff; J K Nicholson; T J Spira
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Detection of IgG3 antibodies specific to the human immunodeficiency virus type 1 (HIV-1) p24 protein as marker for recently acquired infection.

Authors:  I F T Viana; D F Coêlho; M L Palma; E J M Nascimento; G Gu; L F O Lima; L Foti; M A Krieger; C Pilcher; C E Calzavara-Silva; R B Mailliard; C R Rinaldo; R Dhalia; E T A Marques
Journal:  Epidemiol Infect       Date:  2018-06-21       Impact factor: 2.451

Review 4.  HIV-associated immune complex kidney disease.

Authors:  Ehsan Nobakht; Scott D Cohen; Avi Z Rosenberg; Paul L Kimmel
Journal:  Nat Rev Nephrol       Date:  2016-01-19       Impact factor: 28.314

5.  Use of TrpE/Gag fusion proteins to characterize immunoreactive domains on the human immunodeficiency virus type 1 core protein.

Authors:  M G Windheuser; G E Tegtmeier; C Wood
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

6.  Antibodies against the major core protein p24 of human immunodeficiency virus: relation to immunological, clinical and prognostic findings.

Authors:  B O Lindhardt; J Gerstoft; B Hofmann; G Pallesen; L Mathiesen; E Dickmeiss; K Ulrich
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-07       Impact factor: 3.267

7.  Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.

Authors:  P A Broliden; L Morfeldt-Månsson; J Rosen; M Jondal; B Wahren
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

8.  Analysis of oligoclonal antibody bands against individual HIV structural proteins in the CSF of patients infected with HIV.

Authors:  R Kaiser; R Dörries; W Lüer; S Poser; H D Pohle; K Felgenhauer; V ter Meulen
Journal:  J Neurol       Date:  1989-03       Impact factor: 4.849

9.  Prognostic value of serum immunoglobulin A antibodies to pol gene products during HIV-1 infection.

Authors:  A Quesnel; B Pozzetto; P Moja; F Grattard; F R Lucht; J L Touraine; O G Gaudin; C Genin
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

10.  Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection.

Authors:  R Cheingsong-Popov; C Panagiotidi; S Bowcock; A Aronstam; J Wadsworth; J Weber
Journal:  BMJ       Date:  1991-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.